PubMed

Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future.

PMID: 41493254 · 2026-01-01

R, a, c, h, e, l, , L, , Z, i, e, b, a, r, t, ;, , B, a, r, b, a, r, a, , H, e, r, n, a, n, d, e, z, -, R, o, v, i, r, a, ;, , H, e, m, a, , S, u, n, d, a, r, a, m, ;, , S, a, m, a, n, t, h, a, , G, u, h, a, n, ;, , S, a, r, a, n, y, a, , P, , W, y, l, e, s

ЖурналJournal of drugs in dermatology : JDD

Год2026-01-01

PMID41493254

Аннотация

Regenerative dermatology is an emerging subspecialty that seeks to restore the structure and function of healthy skin. The United States lacks comprehensive regulatory guidance for regenerative therapies. This review provides an overview of available therapies within regenerative dermatology, outlining the pathways for approval. Articles on regenerative dermatology in PubMed and guidelines issued by the United States Food and Drug Administration (FDA) were reviewed with emphasis on those publish

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.